Filing Details

Accession Number:
0001193125-20-326084
Form Type:
13G Filing
Publication Date:
2020-12-23 16:42:47
Filed By:
Aspire Capital Fund, Llc
Company:
Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC)
Filing Date:
2020-12-23
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Aspire Capital Fund 0 270,000 0 270,000 270,000 5.05%
Aspire Capital Partners 0 270,000 0 270,000 270,000 5.05%
SGM Holdings Corp. 36-430346 0 270,000 0 270,000 270,000 5.05%
Red Cedar Capital Corp 0 270,000 0 270,000 270,000 5.05%
Chrisko Investors, Inc 0 270,000 0 270,000 270,000 5.05%
WML Ventures Corp. 8 0 270,000 0 270,000 270,000 5.05%
Steven G. Martin 0 270,000 0 270,000 270,000 5.05%
Erik J. Brown 0 270,000 0 270,000 270,000 5.05%
Christos Komissopoulos 0 270,000 0 270,000 270,000 5.05%
William F. Blank, III 0 270,000 0 270,000 270,000 5.05%
Filing

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Cyclacel Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

23254L603

(CUSIP Number)

December 23, 2020

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

Rule 13d-1(b)

 

Rule 13d-1(c)

 

Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 23254L603    13G    Page 2 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Aspire Capital Fund, LLC 27-1406279

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Illinois

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

  0

  6.     

  SHARED VOTING POWER

 

  270,000 (1)

  7.     

  SOLE DISPOSITIVE POWER

 

  0

  8.     

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

  CO

 

(1)

The securities include 270,000 shares of common stock, par value $0.001 per share (the Common Stock) of Cyclacel Pharmaceuticals, Inc. (the Issuer).

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the Securities and Exchange Commission (the SEC) under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 3 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Aspire Capital Partners, LLC 27-1406238

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Illinois

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

  0

  6.     

  SHARED VOTING POWER

 

  270,000 (1)

  7.     

  SOLE DISPOSITIVE POWER

 

  0

  8.     

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

  CO

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 4 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  SGM Holdings Corp. 36-4303462

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.  

  SEC USE ONLY

 

  4.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Illinois

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.     

  SOLE VOTING POWER

 

  0

   6.   

  SHARED VOTING POWER

 

  270,000 (1)

   7.   

  SOLE DISPOSITIVE POWER

 

  0

   8.   

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.  

  TYPE OF REPORTING PERSON (see instructions)

 

  CO

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 5 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Red Cedar Capital Corp. 20-1313891

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.  

  SEC USE ONLY

 

  4.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Illinois

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.     

  SOLE VOTING POWER

 

  0

   6.   

  SHARED VOTING POWER

 

  270,000 (1)

   7.   

  SOLE DISPOSITIVE POWER

 

  0

   8.   

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.  

  TYPE OF REPORTING PERSON (see instructions)

 

  CO

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 6 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Chrisko Investors, Inc. 27-5414284

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.  

  SEC USE ONLY

 

  4.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Illinois

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.     

  SOLE VOTING POWER

 

  0

   6.   

  SHARED VOTING POWER

 

  270,000 (1)

   7.   

  SOLE DISPOSITIVE POWER

 

  0

   8.   

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.  

  TYPE OF REPORTING PERSON (see instructions)

 

  CO

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 7 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  WML Ventures Corp. 82-3709389

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Illinois

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

  0

  6.     

  SHARED VOTING POWER

 

  270,000 (1)

  7.     

  SOLE DISPOSITIVE POWER

 

  0

  8.     

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

  CO

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 8 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Steven G. Martin

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

  0

  6.     

  SHARED VOTING POWER

 

  270,000 (1)

  7.     

  SOLE DISPOSITIVE POWER

 

  0

  8.     

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

  IN

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 9 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Erik J. Brown

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

  0

  6.     

  SHARED VOTING POWER

 

  270,000 (1)

  7.     

  SOLE DISPOSITIVE POWER

 

  0

  8.     

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

  IN

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 10 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Christos Komissopoulos

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

  0

  6.     

  SHARED VOTING POWER

 

  270,000 (1)

  7.     

  SOLE DISPOSITIVE POWER

 

  0

  8.     

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

  IN

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 11 of 15 Pages

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  William F. Blank, III

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

  0

  6.     

  SHARED VOTING POWER

 

  270,000 (1)

  7.     

  SOLE DISPOSITIVE POWER

 

  0

  8.     

  SHARED DISPOSITIVE POWER

 

  270,000 (1)

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  270,000 (1)

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.05% (1)(2)

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

  IN

 

(1)

The securities include 270,000 shares of Common Stock of the Issuer.

(2)

Based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the SEC under Rule 424(b)(5) on December 22, 2020.


CUSIP No. 23254L603    13G    Page 12 of 15 Pages

 

Item 1.

 

(a)   

Name of Issuer

 

Cyclacel Pharmaceuticals, Inc. (Issuer)

(b)   

Address of Issuers Principal Executive Offices

 

200 Connell Drive, Suite 1500, Berkeley Heights, NJ 07922

Item 2.

 

(a)   

Name of Person Filing

 

Aspire Capital Fund, LLC (Aspire Fund)

Aspire Capital Partners, LLC (Aspire Partners)

SGM Holdings Corp. (SGM)

Red Cedar Capital Corp. (Red Cedar)

Chrisko Investors, Inc. (Chrisko)

WML Ventures Corp. (WML Ventures)

Steven G. Martin (Mr. Martin)

Erik J. Brown (Mr. Brown)

Christos Komissopoulos (Mr. Komissopoulos)

William F. Blank, III (Mr. Blank)

(b)   

Address of the Principal Office or, if none, residence

 

The address of the principal business office of each of Aspire Fund, Aspire Partners, SGM, Red Cedar, Chrisko, WML Ventures, Mr. Martin, Mr. Brown, Mr. Komissopoulos and Mr. Blank is:

 

155 N. Wacker Drive, Suite 1600, Chicago, Illinois 60606

(c)   

Citizenship

 

Aspire Fund Illinois

Aspire Partners Illinois

SGM Illinois

Red Cedar Illinois

Chrisko Illinois

WML Ventures Illinois

Mr. Martin United States

Mr. Brown United States

Mr. Komissopoulos United States

Mr. Blank United States

(d)   

Title of Class of Securities

 

Common Stock, par value $0.001 per share (Common Stock).

(e)   

CUSIP Number

 

23254L603


CUSIP No. 23254L603    13G    Page 13 of 15 Pages

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

Reporting person

   Amount
beneficially
owned:
     Percent of
class:
    Sole
power

to vote or
direct the
vote:
     Shared
power to
vote or to
direct
the vote:
     Sole
power to

dispose or
to

direct the
disposition
of:
     Shared
power

to dispose or
to

direct the
disposition
of:
 

Aspire Capital Fund, LLC

     270,000        5.05     0        270,000        0        270,000  

Aspire Capital Partners, LLC

     270,000        5.05     0        270,000        0        270,000  

SGM Holdings Corp.

     270,000        5.05     0        270,000        0        270,000  

Red Cedar Capital Corp.

     270,000        5.05     0        270,000        0        270,000  

Chrisko Investors, Inc.

     270,000        5.05     0        270,000        0        270,000  

WML Ventures

     270,000        5.05     0        270,000        0        270,000  

Steven G. Martin

     270,000        5.05     0        270,000        0        270,000  

Erik J. Brown

     270,000        5.05     0        270,000        0        270,000  

Christos Komissopoulos

     270,000        5.05     0        270,000        0        270,000  

William F. Blank, III

     270,000        5.05     0        270,000        0        270,000  

The percent of class shown in the table above is based on 5,349,896 shares of Common Stock issued and outstanding as reported in a prospectus supplement filed by the Issuer with the Securities and Exchange Commission under Rule 424(b)(5) on December 22, 2020.

Aspire Fund may be deemed the beneficial owner of 270,000 shares of Common Stock of the Issuer. Aspire Partners is the Managing Member of Aspire Fund. SGM is the Managing Member of Aspire Partners. Mr. Martin is the president and sole shareholder of SGM, as well as a principal of Aspire Partners. Mr. Brown is the president and sole shareholder of Red Cedar, which is a principal of Aspire Partners. Mr. Komissopoulos is president and sole shareholder of Chrisko, which is a principal of Aspire Partners. Mr. Blank is the president and sole shareholder of WML Ventures, which is a principal of Aspire Partners.

Pursuant to Section 13(d) of the Act, each of Aspire Partners, SGM, Red Cedar, Chrisko, WML Ventures, Mr. Martin, Mr. Brown, Mr. Komissopoulos and Mr. Blank may be deemed to be a beneficial owner of the Shares held by Aspire Fund.

Pursuant to Rule 13d-4 of the Act, each of Aspire Partners, SGM, Red Cedar, Chrisko, WML Ventures, Mr. Martin, Mr. Brown, Mr. Komissopoulos and Mr. Blank disclaims beneficial ownership of the Shares held by Aspire Fund.

Item 5. Ownership of 5 Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following  ☐.


CUSIP No. 23254L603    13G    Page 14 of 15 Pages

 

Item 6. Ownership of More than 5 Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of a Group.

Not applicable.


CUSIP No. 23254L603    13G    Page 15 of 15 Pages

 

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: December 23, 2020

 

ASPIRE CAPITAL FUND, LLC

BY: ASPIRE CAPITAL PARTNERS, LLC

BY: SGM HOLDINGS CORP.

  

ASPIRE CAPITAL PARTNERS, LLC

BY: SGM HOLDINGS CORP.

By:   

/s/ Steven G. Martin

   By:   

/s/ Steven G. Martin

Name:    Steven G. Martin    Name:    Steven G. Martin
Title:    President    Title:    President
SGM HOLDINGS CORP.    RED CEDAR CAPITAL CORP.
By:   

/s/ Steven G. Martin

   By:   

/s/ Erik J. Brown

Name:    Steven G. Martin    Name:    Erik J. Brown
Title:    President    Title:    President
CHRISKO INVESTORS, INC.    WML VENTURES CORP.
By:   

/s/ Christos Komissopoulos

   By:   

/s/ William F. Blank III

Name:    Christos Komissopoulos    Name:    William F. Blank III
Title:    President    Title:    President
STEVEN G. MARTIN    ERIK J. BROWN

/s/ Steven G. Martin

  

/s/ Erik J. Brown

CHRISTOS KOMISSOPOULOS    WILLIAM F. BLANK III

/s/ Christos Komissopoulos

  

/s/ William F. Blank III


EXHIBIT INDEX

 

Exhibit
Number
  

Exhibit Description

99.1    Joint Filing Agreement
99.2    Power of Attorney